Our results showed that albeit MUC4 levels were low, they were only minimally elevated in higher glioma grades (III and IV) compared to controls, although the difference was not significant, which needs confirmation in a larger cohort of patients (Fig. 6C). The gene discussed is MUC4; the disease is central nervous system cancer.